Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor
Lloyd Paul Aiello(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Thomas A. Ciulla(Norwich Research Park), L. E. Smith, Sven–Erik Bursell(Joslin Diabetes Center), C. Takagi, E. Duh, H. Ishii, M. Jirousek, K. Ways, F. Mori, A. Clermont
Cited by 193
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979